FDA | New draft guidance for PDUFA products

October 11, 2023

The US Food and Drug Administration (FDA) has released an updated preliminary advisory document aimed at assisting sponsors in comprehending the various categories of meetings they can seek to address inquiries related to their applications, while also outlining the timeframes associated with these requests.

The guidance adds two new types of meetings, a Type D meeting for topics of narrow interest and meetings through the INitial Targeted Engagement for Regulatory Advice on CBER ProducTs (INTERACT) pathway for new and innovative technologies. It also now classifies video conference meetings as virtual face-to-face meetings.

This draft guidance, when finalized, will represent the current thinking of the Agency on this topic. Read the full guidance HERE.

Do you need assistance for FDA requirements? Reach out to us!

Send us an email at: info@asphalion.com

Or schedule a free 30-minutes meeting: SCHEDULE A MEETING

Search News & Events

  • Filter by category


Related news and events

Service | Readability test

Did you know that Asphalion can perform readability tests on your behalf?   Asphalion has been providing its clients with the execution of readability tests

Access Consortium | Flyer

The 5 regulatory agencies work together to promote greater regulatory collaboration and alignment of regulatory requirements

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting